Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jun 3, 2026
- Accession no.
- 0001106578-26-000068
- Filed
- Jun 3, 2026
- Trade date
- Jun 2, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.11M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $146.03 | +$1,387,285 | 50,013 | Direct | |
| Jun 2, 2026 | Common Stock | SSaleDisposed | −1,160 | $535.69F2 | −$621,400.4 | 48,853 | Direct | |
| Jun 2, 2026 | Common Stock | SSaleDisposed | −2,056 | $536.62F3 | −$1,103,290.72 | 46,797 | Direct | |
| Jun 2, 2026 | Common Stock | SSaleDisposed | −1,464 | $537.62F4 | −$787,075.68 | 45,333 | Direct | |
| Jun 2, 2026 | Common Stock | SSaleDisposed | −1,149 | $538.81F5 | −$619,092.69 | 44,184 | Direct | |
| Jun 2, 2026 | Common Stock | SSaleDisposed | −2,310 | $539.83F6 | −$1,247,007.3 | 41,874 | Direct | |
| Jun 2, 2026 | Common Stock | SSaleDisposed | −641 | $540.48F7 | −$346,447.68 | 41,233 | Direct | |
| Jun 2, 2026 | Common Stock | SSaleDisposed | −440 | $541.68F8 | −$238,339.2 | 40,793 | Direct | |
| Jun 2, 2026 | Common Stock | SSaleDisposed | −280 | $543.26F9 | −$152,112.8 | 40,513 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 116,910 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $535.16 to $536.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $536.16 to $537.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $537.17 to $538.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $538.24 to $539.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $539.25 to $540.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $540.25 to $540.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $541.41 to $542.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $543.12 to $543.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.